Pfizer, Trump deal could affect drug prices
Digest more
Pfizer's stock price is down materially from its 2021 highs, but it is also up notably from its April 2025 lows.
Of the three highest bidders, Pfizer’s purchase proposal for Metsera was the lowest, regulatory documents reveal. The New ...
The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.
Some women believe the birth control shot caused their meningiomas, a tumor that grows from the lining of the brain.
MarketBeat on MSN
TrumpRx Brings Pfizer Into the Green-Is It a Buy?
Pfizer (NYSE: PFE) is no stranger to income investors. The drugmaker, famous for treatments including Lipitor, Viagra, and ...
Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...
Money Talks News on MSN
Pfizer's 2025 COVID Vaccine Boosts Immunity 4x, Access Severely Limited Nationwide
Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback